Pharmacy chains activity analysis

Pharmacy chains activity analysis

Russian pharmaceuticals retail chain segment evaluation, both on the level of the state and in particular regions. Pharmacy chains development forecast

Forecasting

Product sales and separate market development forecast, based on unique mathematical models

Business and marketing plan development

Development of detailed business-plans, required to evaluate the reasonability of project start

Search of partners for contract production in Russia

Potential partners search and evaluation, based on their technical opportunities, appropriate experience, and reputation

Monitoring of import substitution

assessment of the main trends of import substitution policies and localization processes in the pharmaceutical market in Russia, the key beneficiaries and companies at risk

Database Update: Pharmaceutical Drug Import to Russia (June 2017)

Monday, July 17, 2017

Between January and June 2017, Russia imported 238.5 bln RUB worth of ready-made drugs (free circulation prices), which is 8.1% higher in monetary terms. Due to the poor June performance, the long-term dynamics are -1%. The in-bulk import has been falling down for four months, with 42.7 bln RUB, which is 25.5% lower than that of 2016.

In physical terms, Russia import 946.1 mln units of ready-made drugs, which is 6% higher than that of 2016. In June, the increase in the import was only 1% if calculated in units due to the decrease in consumer packages. If calculated in minimum dosage units, (MDU), the import of ready-made products has fallen by 5% (to 17.1 bln MDUs.) While the in-bulk import has grown by 9.2% in physical terms, it amounts to 2.2 bln MDUs, that is why the total import dynamics are -1%.

Among the 10 largest importers of ready-made drugs, GSK has the best progress in monetary terms (+60%), while TEVA has the worst dynamics (-27%). Among the largest importers of in-bulk products, Octapharma has the best progress (+202%), while Roche has the worst dynamics (-66%).

Read more about pharmaceutical drug import to Russia (May performance) here: http://rncph.com/news/16_06_2017

Dynamics of import of pharmaceuticals, including homeopathic and seawater drugs, to Russia, free circulation prices including customs clearance, RUB (January 2016 – June 2017)

Share: